This product is a Camelid antibody that recognizes NadA.
Figure 1 VHH Interacting with NadA peptides could block the interaction between rec-NadA and proteins of hBMEC.
Preincubated was performed to block receptor binding site on rec-NadA by VHH selected against either NadA-gdA33−K69 (C) or NadA-ccL121−K158 (D) or combination of VHH selected against NadA-gdA33−K69 and NadA-ccL121−K158 (E).
Kulkarni, A., Mochnáčová, E., Majerova, P., Čurlík, J., Bhide, K., Mertinková, P., & Bhide, M. (2020). Single domain antibodies targeting receptor binding pockets of Nada restrain adhesion of neisseria meningitidis to human brain microvascular endothelial cells. Frontiers in Molecular Biosciences, 7, 573281.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-284 | Recombinant Mouse Anti-NadA Antibody | WB, ELISA, FuncS | IgG |
PABC-143 | Recombinant Mouse Anti-N. meningitidis NadA Antibody (33E8) | FACS | IgG |
There are currently no Customer reviews or questions for HPAB-A1203-YJ. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.